Shohei Mizuno

1.1k citations
56 papers · 635 indexed · h-index 13

Shohei Mizuno

52 papers receiving 628 citations

Peers

Shohei Mizuno
Comparison fields: 5 of 84
  • Hematology 286
  • Cancer Research 140
  • Geriatrics and Gerontology 22
  • Immunology 101
  • Molecular Biology 301
Replace Wanmao Ni with:
Wanmao Ni China
Sandeep Batra United States
Debora Valli Italy
Melissa Garcia United States
Stefan J. Müller Germany
François Hermetet France
Stephany Corrêa Brazil
Mark N. Ho United States
Francesca Conserva Italy
Zhuoxin Cheng China
Shohei Mizuno relative to Wanmao Ni China Wanmao Ni's profile →
Citations per field
00.5×2.8×
Wanmao Ni · 1×
Citations per year

Countries citing papers authored by Shohei Mizuno

Since Specialization
Citations

This map shows the geographic impact of Shohei Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shohei Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shohei Mizuno more than expected).

Fields of papers citing papers by Shohei Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shohei Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shohei Mizuno. The network helps show where Shohei Mizuno may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shohei Mizuno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shohei Mizuno Line = papers co-authored together Shohei Mizuno links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20242
3 20241
4 202216
5 20229
6 20213
7 202111
8 20214
9 20214
10 202013
11 20187
12 201816
13 201720
14 20174
15 20163
16 20155
17 201458
18 201312
19 2010102
20
Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese.
19951

About Shohei Mizuno

Shohei Mizuno is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health, having authored 56 papers that have together received 635 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (28 papers), Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (12 papers), Multiple Myeloma Research and Treatments (6 papers), Immune Cell Function and Interaction (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Hematology (286 citations), Cancer Research (140 citations) and Geriatrics and Gerontology (22 citations). Shohei Mizuno has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Ichiro Hanamura, Hiroshi Miwa, Masakazu Nitta, Masato Shikami, Akiyoshi Takami, Miyuki Takahashi, J. Luis Espinoza, Shinji Nakao, Akira Imamura and Yoshiko Atsuta. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026